Zdrowie i gospodarka · 23/10/2017
FDA Announces New Draft Guidance for Generic Methylphenidate Hydrochloride Oral Extended-Release Tablets
The Food and Drug Administration has released a new draft guidance for the pharmaceutical industry on the development of generic methylphenidate hydrochloride oral extended-release tablets, outlining product-specific recommendations for bioequivalence studies to support abbreviated new drug applications.